Needham & Company LLC Reaffirms Buy Rating for OrthoPediatrics (NASDAQ:KIDS)

OrthoPediatrics (NASDAQ:KIDS – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a research report issued on Wednesday, Benzinga reports. They currently have a $37.00 price objective on the stock. Needham & Company LLC’s price objective suggests a potential upside of 16.28% from the stock’s previous close. Other equities […]

Related Keywords

United States ,Wellington ,New Zealand General ,New Zealand ,Josephw Hauser ,Danielj Gerritzen , ,Vanguard Group Inc ,Wellington Management Group ,Nuveen Asset Management ,Barclays Plc ,Goldman Sachs Group Inc ,Needham Company ,Orthopediatrics Corp ,Nasdaq ,Get Free Report ,General Counsel Daniel ,Management Group ,Sachs Group ,Asset Management ,Pediatrics Corp ,Orthopediatrics Daily ,Orthopediatrics ,Nasdaq Kids ,Kids ,Medical ,Reiterated Rating ,Needham Company Llc ,